GYNECOLOGY
FRIDAY, NOVEMBER 25
|
08:30-10:00 |
HALL B | |
|
Capsule |
Dilemmas in daily care, which you must deal with. Concerning adnexal masses and heavy menstrual bleeding | |
|
Chairpersons |
Justin Clark, UK |
|
| 08:30-08:45 |
What is the best referral policy for patients with an adnexal mass? |
|
| 08:45-09:15 | Differentiating benign form malignant cyst >> how to recognize less common types of benign adnexal masses (struma ovarii/ Brenner tumor/ Sertoli Leydig cell) Jeroen Kaijser, Netherlands |
|
| 09:15-09:30 |
Treatment options in case of HMB with intramural fibroids? |
|
| 09:30-09:45 |
Is TLH really superior to abdominal hysterectomy ? |
|
| 09:45-10:00 |
Endometrial ablation under local anesthetics – is it feasible? |
|
| 10:00-10:20 | Coffee break, e-poster viewing and visit the exhibition | Exhibition Area |
|
10:20-11:50 |
HALL B | |
|
Capsule |
Is genetics a routine tool for predicting menopause, understanding POI and personalized clinical practice? | |
|
Chairpersons |
Micheline Misrahi, France |
|
| 10:20-10:40 |
New POI registry for a new era of global collaboration |
|
| 10:40-11:05 |
Over-view of genes involved in POI and physiological menopause. National genomics projects |
|
| 11:05-11:25 |
Shared mechanism and genetics between the age of physiological menopause, early menopause and POI |
|
| 11:25-11:50 |
Is there an association between menstrual cycle length and ovarian reserve biomarkers during the reproductive life? |
|
| 11:50-12:00 | Break |
|
12:00-13:30 |
HALL B | |
|
Capsule |
No agreement exists on the preferred current treatment of uterine malformation. | |
| Chairpersons |
Peggy Geomini, Netherlands |
|
| 12:00-12:15 |
T-Shaped, Y-Shaped, Dysmorophic – a real reproductive problem or a new trend |
|
| 12:15-12-45
12:15 |
Debate: Dysmorphic Uterus, is it a real infertility problem? Is the solution surgical? Pro: Sergio Haimovich, Israel It is a real infertility problem, but the solution is not surgical: Ben Mol, Australia Discussion |
|
| 12:45-13:15
12:45 |
Debate: Uterine septum in infertility: To treat or not to treat? |
|
| 13:15-13:30 |
Endometrial ablation under local anesthetics – is it feasible? |
|
| 13:30-14:30 | Lunch break, moderated e-posters and visit the exhibition | Exhibition Area |
| 14:30-16:30 | HALL B | |
|
Capsule |
The suggestion to treat menopause with ovarian tissue reimplantation is highly controversial. |
|
|
Chairpersons |
Justin Clark, UK Dorenda van Dijken, Netherlands |
|
| 14:30-14:50 |
Endocrine disruptors in fertility |
|
| 14:50-15:20
14:50 |
Debate: Should ovarian tissue reimplantation be considered for all women to postpone menopause |
|
| 15:20-15:35 |
Postmenopausal hormone treatment and the risk for malignancies |
|
| 15:35-16:00 |
Can AMH predict menopause |
|
| 16:00-16:30 | Progesterone from ovulatory menstrual cycles is a major cause of breast cancer Herjan Coelingh Bennink, Netherlands |
|
| 16:30-16:50 | Coffee break, e-poster viewing and visit the exhibition | Exhibition Area |
| 16:50-18:20 | HALL B | |
|
Capsule |
The use of androgens and the length of HRT treatment are unsolved. | |
|
Chairpersons |
Christian Egarter, Austria Nick Panay, UK |
|
| 16:50-17:25
16:50 |
Debate: Should androgens be routinely added to menopause treatment Yes: Alessandra Graziottin, Italy No: Dorenda van Dijken, Netherlands Discussion |
|
| 17:25-18:00
17:25 |
Debate: Hormone therapy started in premature or early menopause, should be continued for life to prevent chronic diseases For: Nick Panay, UK Against: Mark Brincat, Malta Discussion |
|
| 18:00-18:20 |
Postmenopausal hormone treatment and the bone |
|